Literature DB >> 24581581

Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women.

Brian W Whitcomb1, Sunni L Mumford2, Neil J Perkins2, Jean Wactawski-Wende3, Elizabeth R Bertone-Johnson4, Kristine E Lynch4, Enrique F Schisterman2.   

Abstract

OBJECTIVE: To assess the utility of urinary cytokines for monitoring reproductive function by considering detection, variation across the menstrual cycle, and relations with hormones.
DESIGN: Longitudinal cohort study.
SETTING: Academic institution. PATIENT(S): Healthy, reproductive-aged women with self-reported regular menstrual cycles and at least one observed ovulatory cycle (n = 248). INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Urinary cytokines measured by 30-plex immunoassays in 3,550 biospecimens, and nested random-effects analysis of variance (ANOVA) and marginal structural models used to evaluate variability and relations with hormones. RESULT(S): For 24 of 30 evaluated factors, detectable levels were observed in at least 50% of urine samples. Interleukin-6 (IL-6), IL-8, IL-10, IL-15, granulocyte colony stimulating factor (G-CSF), hepatocyte growth factor (HGF), interferon-α (IFN-α), and RANTES (regulated upon activation normal T-cell expressed and secreted) levels varied significantly across the menstrual cycle. The proinflammatory factors IL-1β, IL-6, IL-8, and HGF were 1.5-3 times higher during menses than the late follicular phase. In marginal structural models, IL-1β, IL-6, IL-8 were associated with lower estradiol and progesterone concentrations. CONCLUSION(S): Variability during the menstrual cycle and correlations with reproductive hormone levels support a role of cytokines in the menstrual cycle; however, because of the limited variability for most cytokines considered, the utility of urine as a matrix for assessment of inflammation in menstrual cycle function appears limited for clinical purposes.
Copyright © 2014 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Keywords:  Chemokines; cytokines; immunology; inflammation; menstrual cycle

Mesh:

Substances:

Year:  2014        PMID: 24581581      PMCID: PMC4008697          DOI: 10.1016/j.fertnstert.2014.01.027

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  47 in total

1.  Urinary cytokines for assessing inflammation in HIV-associated wasting.

Authors:  S Rivera; F R Sattler; H Boyd; T Auffenberg; S Nakao; L L Moldawer
Journal:  Cytokine       Date:  2001-03-07       Impact factor: 3.861

2.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

Review 3.  Leukocyte networks and ovulation.

Authors:  Mats Brännström; Anders Enskog
Journal:  J Reprod Immunol       Date:  2002 Oct-Nov       Impact factor: 4.054

4.  Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells.

Authors:  Ali Akoum; André Lemay; Rodolphe Maheux
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

5.  Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells.

Authors:  N R Keller; E Sierra-Rivera; E Eisenberg; K G Osteen
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

6.  Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion.

Authors:  M von Wolff; C J Thaler; T Strowitzki; J Broome; W Stolz; S Tabibzadeh
Journal:  Mol Hum Reprod       Date:  2000-07       Impact factor: 4.025

Review 7.  Human endometrial angiogenesis.

Authors:  C E Gargett; P A Rogers
Journal:  Reproduction       Date:  2001-02       Impact factor: 3.906

8.  The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments.

Authors:  L Al-Harthi; D J Wright; D Anderson; M Cohen; D Matity Ahu; J Cohn; S Cu-Unvin; D Burns; P Reichelderfer; S Lewis; S Beckner; A Kovacs; A Landay
Journal:  J Interferon Cytokine Res       Date:  2000-08       Impact factor: 2.607

9.  Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein.

Authors:  K Yanagi; S Makinoda; R Fujii; S Miyazaki; S Fujita; H Tomizawa; K Yoshida; T Iura; T Takegami; T Nojima
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

10.  Quantification of proinflammatory cytokines in the urine of congestive heart failure patients. Its relationship with plasma levels.

Authors:  Rafael Sirera; Antonio Salvador; Ildefonso Roldán; Raquel Talens; Andrés González-Molina; Miguel Rivera
Journal:  Eur J Heart Fail       Date:  2003-01       Impact factor: 15.534

View more
  12 in total

1.  Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia.

Authors:  Barbara L Andersen; Neha Godiwala Goyal; David M Weiss; Travis D Westbrook; Kami J Maddocks; John C Byrd; Amy J Johnson
Journal:  Cancer       Date:  2018-05-14       Impact factor: 6.860

2.  Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions.

Authors:  Rachel D Freed; Lushna M Mehra; Daniel Laor; Manishkumar Patel; Carmen M Alonso; Seunghee Kim-Schulze; Vilma Gabbay
Journal:  World J Biol Psychiatry       Date:  2018-08-16       Impact factor: 4.132

3.  Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients.

Authors:  Serena Tedesco; Maria Pia Adorni; Nicoletta Ronda; Roberta Cappellari; Roberto Mioni; Mattia Barbot; Silvia Pinelli; Mario Plebani; Chiara Bolego; Carla Scaroni; Franco Bernini; Gian Paolo Fadini; Andrea Cignarella
Journal:  Endocrine       Date:  2019-04-16       Impact factor: 3.633

4.  Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter.

Authors:  Rong-Yi Chen; Yi-Ming Fan; Qiuyang Zhang; Sen Liu; Qingli Li; Guo-Lin Ke; Chen Li; Zongbing You
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

5.  A prospective study of inflammatory biomarker levels and risk of early menopause.

Authors:  Elizabeth R Bertone-Johnson; JoAnn E Manson; Alexandra C Purdue-Smithe; Susan E Hankinson; Bernard A Rosner; Brian W Whitcomb
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

6.  Preoperative Diagnosis of Endometriosis.

Authors:  Nicolas Galazis; Tariq Miskry
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

7.  Changing to a Low-Polyphenol Diet Alters Vascular Biomarkers in Healthy Men after Only Two Weeks.

Authors:  Sara Hurtado-Barroso; Paola Quifer-Rada; José Fernando Rinaldi de Alvarenga; Silvia Pérez-Fernández; Anna Tresserra-Rimbau; Rosa M Lamuela-Raventos
Journal:  Nutrients       Date:  2018-11-14       Impact factor: 5.717

8.  Plasma Interleukin-10 Levels Are Altered in Women with Severe Premenstrual Syndrome: A Preliminary Study.

Authors:  Kaori Yama; Yuki Asari; Aiko Ono; Maiko Machida; Jun Miura
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-03-04

Review 9.  Acupuncture for Primary Dysmenorrhea: A Potential Mechanism from an Anti-Inflammatory Perspective.

Authors:  Wen-Yan Yu; Liang-Xiao Ma; Zhou Zhang; Jie-Dan Mu; Tian-Yi Sun; Yuan Tian; Xu Qian; Yi-Dan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-03       Impact factor: 2.629

10.  Acupuncture Alleviates Menstrual Pain in Rat Model via Suppressing Eotaxin/CCR3 Axis to Weak EOS-MC Activation.

Authors:  Wen-Yan Yu; Liang-Xiao Ma; Yuan Tian; Jie-Dan Mu; Zhou Zhang; Tian-Yi Sun; Xu Qian; Jun-Xiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.